[go: up one dir, main page]
More Web Proxy on the site http://driver.im/

Pangal et al., 2017 - Google Patents

Current developments of C3-substituted coumarin hybrids as anti-cancer agents

Pangal et al., 2017

View PDF
Document ID
7951752082525851700
Author
Pangal A
Shaikh J
Khan E
Publication year
Publication venue
Int. J. Pharm. Sci. Rev. Res

External Links

Snippet

ABSTRACT Coumarin (benzopyran-2-one or chromen-2-one) is a fused benzene and pyrone ring system which prompt biological investigation to assess their potential therapeutic significance. It possesses immeasurable anticancer potential with minimum side …
Continue reading at scholar.archive.org (PDF) (other versions)

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D311/00—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only hetero atom, condensed with other rings
    • C07D311/02—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only hetero atom, condensed with other rings ortho- or peri-condensed with carbocyclic rings or ring systems
    • C07D311/04—Benzo[b]pyrans, not hydrogenated in the carbocyclic ring
    • C07D311/06—Benzo[b]pyrans, not hydrogenated in the carbocyclic ring with oxygen or sulfur atoms directly attached in position 2
    • C07D311/08—Benzo[b]pyrans, not hydrogenated in the carbocyclic ring with oxygen or sulfur atoms directly attached in position 2 not hydrogenated in the hetero ring
    • C07D311/12—Benzo[b]pyrans, not hydrogenated in the carbocyclic ring with oxygen or sulfur atoms directly attached in position 2 not hydrogenated in the hetero ring substituted in position 3 and unsubstituted in position 7
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D311/00—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only hetero atom, condensed with other rings
    • C07D311/02—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only hetero atom, condensed with other rings ortho- or peri-condensed with carbocyclic rings or ring systems
    • C07D311/04—Benzo[b]pyrans, not hydrogenated in the carbocyclic ring
    • C07D311/22—Benzo[b]pyrans, not hydrogenated in the carbocyclic ring with oxygen or sulfur atoms directly attached in position 4
    • C07D311/26—Benzo[b]pyrans, not hydrogenated in the carbocyclic ring with oxygen or sulfur atoms directly attached in position 4 with aromatic rings attached in position 2 or 3
    • C07D311/28—Benzo[b]pyrans, not hydrogenated in the carbocyclic ring with oxygen or sulfur atoms directly attached in position 4 with aromatic rings attached in position 2 or 3 with aromatic rings attached in position 2 only
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
    • C07D405/02—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
    • C07D405/12—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings linked by a chain containing hetero atoms as chain links

Similar Documents

Publication Publication Date Title
Gao et al. Chalcone hybrids as potential anticancer agents: Current development, mechanism of action, and structure‐activity relationship
Menezes Arylidene indanone scaffold: medicinal chemistry and structure–activity relationship view
Emami et al. Current developments of coumarin-based anti-cancer agents in medicinal chemistry
Sandhu et al. Coumarin hybrids as novel therapeutic agents
Sui et al. Recent advances on synthesis and biological activities of aurones
Zhang et al. Piperazine skeleton in the structural modification of natural products: a review
Decker Hybrid molecules incorporating natural products: applications in cancer therapy, neurodegenerative disorders and beyond
Ahmadi et al. Recent applications of vinyl sulfone motif in drug design and discovery
Liang et al. Exploration and synthesis of curcumin analogues with improved structural stability both in vitro and in vivo as cytotoxic agents
Al-Said et al. Dapson in heterocyclic chemistry, part VIII: synthesis, molecular docking and anticancer activity of some novel sulfonylbiscompounds carrying biologically active 1, 3-dihydropyridine, chromene and chromenopyridine moieties
Wu et al. Synthesis and activity of combretastatin A-4 analogues: 1, 2, 3-thiadiazoles as potent antitumor agents
Karagöz et al. Access to new highly potent antileukemia, antiviral and antimalarial agents via hybridization of natural products (homo) egonol, thymoquinone and artemisinin
Goud et al. Recent developments of target based coumarin derivatives as potential anticancer agents
Xia et al. Tubulin inhibitors binding to colchicine-site: a review from 2015 to 2019
Liu et al. Synthesis of xanthone derivatives and studies on the inhibition against cancer cells growth and synergistic combinations of them
KR20030005336A (en) Piperazinedione compounds
Patel et al. Pyranocarbazole derivatives as potent anti-cancer agents triggering tubulin polymerization stabilization induced activation of caspase-dependent apoptosis and downregulation of Akt/mTOR in breast cancer cells
Wang et al. Synthesis of new ent-labdane diterpene derivatives from andrographolide and evaluation of their anti-inflammatory activities
He et al. Design, synthesis and biological evaluation of novel thiosemicarbazone-indole derivatives targeting prostate cancer cells
Duangdee et al. Design synthesis and anti-proliferative activity of some new coumarin substituted hydrazide–hydrazone derivatives
Pangal et al. Current developments of C3-substituted coumarin hybrids as anti-cancer agents
Wei et al. Design and synthesis of novel Flavone-based histone deacetylase inhibitors antagonizing activation of STAT3 in breast cancer
Rehman et al. Synthesis, characterization, in vitro antimicrobial, and U2OS tumoricidal activities of different coumarin derivatives
Zhao et al. Synthesis and evaluation of new compounds bearing 3-(4-aminopiperidin-1-yl) methyl magnolol scaffold as anticancer agents for the treatment of non-small cell lung cancer via targeting autophagy
Güiza et al. Synthesis and in vitro evaluation of substituted tetrahydroquinoline-isoxazole hybrids as anticancer agents